Skip to main content

María José Baena, Manager Production Support and Process Improvement
Enric Domènech, Production Support Technician

Many drugs, especially newly developed substances, have lower solubility and lower permeability, which limits their oral bioavailability. The dissolution rate can be enhanced by using micronized active pharmaceutical ingredients (APIs).

The process of micronization allows to get fine particles and to achieve a specific particle size of an API. Drug powder properties are decisive for the manufacturing of a dosage form and for therapeutic success, the characterization of the particle surface and powder properties plays an important role.

AGC Pharma Chemicals opted for a dual system mill from Hosokawa Alpine to enable wider applications. Thanks to the multi-process system including bed opposed jet milling and mechanical impact milling, the company is able to get fine and ultrafine particle size (< 5 µm) but also it is able to obtain a coarser particle size with the mechanical mill.

More than 30% of today’s APIs require micronization. In the forthcoming years, it is expected this figure to grow due to the rise of high active pharmaceutical ingredients (HAPIs), which will require the usage of particle size reduction technologies.

AGC Pharma Chemicals, a reliable CDMO for small molecule APIs based in Spain and Japan, rapidly set up a micronization plant to broaden its service level for customers. In addition, the unit can operate HAPIs (OEL band 1-10µg/m3).

Latest News

Events & ConventionsAGC Pharma Chemicals to Attend the 54th Organic Process Research & Development Conference in Lisbon
26th September 2025

AGC Pharma Chemicals to Attend the 54th Organic Process Research & Development Conference in Lisbon

AGC Pharma Chemicals will be attending the 54th Organic Process Research and Development Conference in Lisbon from September 29 to October 1, 2025. This premier gathering of process chemists and…
NoticiasAGC Pharma Chemicals inaugurates a new advanced manufacturing plant in Malgrat de Mar (Barcelona), with an investment of over 100 million euros
25th September 2025

AGC Pharma Chemicals inaugurates a new advanced manufacturing plant in Malgrat de Mar (Barcelona), with an investment of over 100 million euros

AGC Pharma Chemicals inaugurated its new state-of-the-art manufacturing plant in Malgrat de Mar, Barcelona, representing an investment of over 100 million euros. The new facility marks a key milestone in…
All of ArticlesCDMO ProcessesThe Power of Small Particles: Understanding Micronization in Small Molecule APIs
26th June 2025

The Power of Small Particles: Understanding Micronization in Small Molecule APIs

Did you know that over 70% of new drug molecules face significant bioavailability challenges? The Paradigm Shift in Pharma With over 30% of active pharmaceutical ingredients (APIs) requiring micronization and…